Intervention

Report and compare changes in a non-inferiority analysis of the toxicities reported according to the Common Terminology Criteria for Adverse Events (CTCAE)

ClinicalTrials.gov intervention label

Clinical trials1

Recruiting0

Common conditions3

Lead sponsors shown1

Clinical trials

1 shown

Pelvic Nodes Ultra-Hypo vs Conventionally Fractionated IMRT With HDR Boost in Prostate Cancer.NCT05820633 · 2022-09-01

SUSPENDED

Common conditions

Node; Prostate1 Prostate Cancer1 Radiotherapy Side Effect1

Leading sponsors

CHU de Quebec-Universite Laval1

Trial status mix

SUSPENDED1

Phase mix

NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.